Clinical Trial Update: Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma [Phase 1]

View source ↗

Summary

Phase I/Ib trial assessing the combination of pembrolizumab with vorinostat in patients with advanced renal cell carcinoma or bladder cancer; the study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Renal Cell Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• Zolinza (vorinostat)

Snippet

Sponsor: Nabil Adra | Conditions: Renal Cell Carcinoma, Urinary Bladder Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2024-11-18